SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001424884-11-000163
Filing Date
2011-11-21
Accepted
2011-11-21 15:52:06
Documents
11
Period of Report
2011-09-30
Filing Date Changed
2011-11-21

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 711942
2 exhibit31-1.htm EX-31.1 16781
3 exhibit31-2.htm EX-31.2 14867
4 exhibit32-1.htm EX-32.1 5867
5 exhibit32-2.htm EX-32.2 5891
  Complete submission text file 0001424884-11-000163.txt   2676091

Data Files

Seq Description Document Type Size
6 tpiv-20110930.xml EX-101.INS 382521
7 tpiv-20110930.xsd EX-101.SCH 14253
8 tpiv-20110930_cal.xml EX-101.CAL 37166
9 tpiv-20110930_def.xml EX-101.DEF 87527
10 tpiv-20110930_lab.xml EX-101.LAB 83239
11 tpiv-20110930_pre.xml EX-101.PRE 94005
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 111219032
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1